~~<i id='01E18FB1B6'><strike id='01E18FB1B6'><tt id='01E18FB1B6'><pre id='01E18FB1B6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：hotspot 2025-08-26 10:52:33 - browse：9

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： It's time to get medical device identifiers over the finish line

focus

hotspot

leisure time

focus

AneffectivetreatmentforAlzheimer’sdiseasehaslongbeenaholygrailinthepharmaceuticalindustry.InearlyJun

WSS

Petition to FDA: Get the lead out of consumer hair dyes

Supreme Court mifepristone arguments center on docs' right to sue

NIH fellows want a pay raise. Will that mean less money for grants?

Readout Newsletter: Merck, Vertex, and Viking updates

Primary care physicians play key roles in Alzheimer's management

Readout LOUD podcast: mifepristone case, GLP

entertainment

entertainment

focus

Cancer drug shortages should be causing more outrage

Study says nonprofit hospitals fall short in charity care spending

Apple is now the first public company to be valued at $3 trillion

It's time to get medical device identifiers over the finish line

23andMe had bad news about my health. I wish a person had delivered it

Oprah kicked off a national conversation on obesity. Let's have it

DIEP, the 'gold standard' of breast reconstruction, is under threat

Petition to FDA: Get the lead out of consumer hair dyes

In age of alternative facts, a scholarly course on calling out crap

Decaf coffee targeted by food safety group under obscure FDA rule

focus

Steward Health Care has deal to sell doctor network to UnitedHealth

Decaf coffee targeted by food safety group under obscure FDA rule

NIH fellows want a pay raise. Will that mean less money for grants?

Why 40% Americans with Parkinson’s don’t see a neurologist

Steward Health Care has deal to sell doctor network to UnitedHealth

Iowa House, Senate pass 6

hotspot

leisure time

focus

focus